학술논문

Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 10 January 2024, 30(1):82-93)
Subject
Language
English
ISSN
15573265
10780432